STRATA Skin Sciences Full Year 2023 Earnings: Misses Expectations
STRATA Skin Sciences, Inc. SSKN | 2.69 | -1.28% |
STRATA Skin Sciences (NASDAQ:SSKN) Full Year 2023 Results
Key Financial Results
- Revenue: US$33.4m (down 7.8% from FY 2022).
- Net loss: US$10.8m (loss widened by 95% from FY 2022).
- US$0.31 loss per share (further deteriorated from US$0.16 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
STRATA Skin Sciences Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 3.8%. Earnings per share (EPS) also missed analyst estimates by 44%.
Looking ahead, revenue is forecast to grow 2.1% p.a. on average during the next 2 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are down 22% from a week ago.
Risk Analysis
It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with STRATA Skin Sciences, and understanding these should be part of your investment process.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
